Opinion | Published:

Genetic equity

Nature Reviews Genetics volume 5, pages 796800 (2004) | Download Citation

Subjects

Abstract

This paper proposes, elaborates and defends a principle of genetic equity. In doing so it articulates, explains and justifies what might be meant by the concept of 'human dignity' in a way that is clear, defensible and consistent with, but by no means the same as, the plethora of appeals to human dignity found in contemporary bioethics, and more particularly in international instruments on bioethics. We propose the following principle of genetic equity: humans are born equal; they are entitled to freedom from discrimination and equality of opportunity to flourish; genetic information may not be used to limit that equality.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Do elderly people have human rights? Respect for equality and the treatment of the older person: declarations of human rights and age-based rationing. Camb. Q. Healthc. Ethics (in the press).

  2. 2.

    Du Contract Social, ou Principes du Droit Politique (Chez Rey MM, Amsterdam, 1972).

  3. 3.

    The Republic Book V, 451–457 (Stephanus edn, 1578).

  4. 4.

    Taking Rights Seriously 227 (Duckworth, London, 1977).

  5. 5.

    in Utilitarianism (ed. Mary Warnock) 319 (Collins/Fontana, London, 1962).

  6. 6.

    Does justice require that we be ageist? Bioethics 8, 74–84 (1994).

  7. 7.

    Could we hold people responsible for their own adverse health? J. Contemp. Health Law Policy 1, 100–106 (1996).

  8. 8.

    What is the good of health care? Bioethics 10, 269–292 (1996).

  9. 9.

    Just Health Care (Cambridge Univ. Press, 1985).

  10. 10.

    et al. The Allocation of Health Care Resources (Ashgate, UK, 1998).

  11. 11.

    The World Medical Association. The World Medical Association Declaration of Helsinki, [], (adopted by the 52nd General Assembly, Edinburgh, Scotland, October 2000).

  12. 12.

    United Nations. The Universal Declaration of Human Rights Articles 1 and 2, [], (General Assembly resolution 217A (III), 10 December 1948).

  13. 13.

    Council of Europe. The European Convention on Human Rights Articles 2 and 14, [], (Rome, 4 November 1950).

  14. 14.

    Leviathan (ed. Oakshott, M.) (Blackwell, Oxford, 1960).

  15. 15.

    Sovereign Virtue 1 (Harvard Univ. Press, 2000).

  16. 16.

    UNESCO. Universal Declaration on the Human Genome and Human Rights [], (adopted by the General Conference of UNESCO on 11 November 1997).

  17. 17.

    Clone mammals...clone man? Nature 386, 119 (1997).

  18. 18.

    Opinion of the group of advisers on the ethical implications of biotechnology to the European Commission No 9. [], (28 May 1997).

  19. 19.

    Cloning, dignity and ethical revisionism. Nature 388, 320 (1997).

  20. 20.

    Is cloning an attack on human dignity? Nature 387, 754 (1997).

  21. 21.

    The European Court of Human Rights. Case of Vo v. France (application no. 53924/00) [], (Strasbourg, 8 July 2004).

  22. 22.

    Taking Rights Seriously Ch. 9 (Duckworth, London, 1977).

Download references

Acknowledgements

The authors acknowledge the support of a project grant from the European Commission for the project EUREKA under its Quality of Life and Management of Living Resources Programme, 2002. An important part of the impetus for this paper has come from the membership of both authors of the UK Human Genetics Commission (HGC). We thank all our colleagues on the commission for many helpful comments and suggestions but emphasize that the responsibility for this paper and for the ideas it contains is that of the authors and this paper does not necessarily represent the views nor the policy of HGC nor those of any other of its members. A version of the principle of genetic equity was originally proposed in an informal working paper by J.S., J.H. and Simona Giordano, called 'Genetic Equality' and submitted to the HGC. We thank two anonymous referees for helpful comments.

Author information

Affiliations

  1. John Harris is at the Institute of Medicine, Law and Bioethics, School of Law, University of Manchester, Oxford Road, Manchester M13 9PL, UK.

    • John Harris
  2. John Sulston is at the Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

    • John Sulston

Authors

  1. Search for John Harris in:

  2. Search for John Sulston in:

Competing interests

The authors declare no competing financial interests.

Glossary

AFFIRMATIVE ACTION

The practice of counting features such as gender or skin colour affirmatively as a qualification for educational or employment opportunities to mitigate or help to eradicate the effects of discrimination.

COMMON-LAW RIGHTS

The rights that arise in common-law jurisdictions such as England and the United States, which are usually rights that are traditionally recognized by the courts (case law), as opposed, for example, to rights established by a parliament (statute law).

CONSEQUENTIALIST

A person who adheres broadly to the philosophical idea of consequentialism, which holds that actions are to be ethically evaluated in terms of their consequences, rather than in terms of the agent's intentions or some absolute standard.

CONTINGENT FEATURES

Features that are not necessary or logically entailed.

GENETIC EXCEPTIONALISM

The singling out of genetic criteria for special attention, often with the implication that it is inappropriate to do so.

GENE THERAPY

The introduction of an active gene into a patient to supply a missing function or to offset susceptibility to a disease.

KANTIAN ETHICS

In broad terms, the name given to a trend in ethics that follows the ethical approach of Immanuel Kant. In this context, it refers to the idea that people should be treated always as ends in themselves and never only as a means to the ends of others.

MORAL CLAIMS

Claims that people make on each other or society, the justification of which is ethical rather than legal or customary.

PHARMACOGENETICS

Pharmaceutical treatment that is tailored to the individual, with regard to genetic criteria — for example, by choice of drug or dosage.

REPRODUCTIVE CLONING

Cloning, either by nuclear substitution or by embryo splitting, resulting in a live birth. It occurs naturally in the case of identical twins.

STATUTORY ENTITLEMENTS

The rights established by statute or other acts of the legislature.

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI

A declaration of principles and standards for human-subject research that is widely accepted in the research community.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrg1454

Further reading